These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 33626936)
1. Emerging advances in cationic liposomal cancer nanovaccines: opportunities and challenges. Ahmad MZ; Ahmad J; Alasmary MY; Abdel-Wahab BA; Warsi MH; Haque A; Chaubey P Immunotherapy; 2021 Apr; 13(6):491-507. PubMed ID: 33626936 [TBL] [Abstract][Full Text] [Related]
2. Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges. Ahmad MZ; Ahmad J; Haque A; Alasmary MY; Abdel-Wahab BA; Akhter S Expert Rev Vaccines; 2020 Nov; 19(11):1053-1071. PubMed ID: 33315512 [No Abstract] [Full Text] [Related]
3. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles. Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760 [TBL] [Abstract][Full Text] [Related]
4. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014 [TBL] [Abstract][Full Text] [Related]
5. Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy. Cai T; Liu H; Zhang S; Hu J; Zhang L J Nanobiotechnology; 2021 Nov; 19(1):389. PubMed ID: 34823541 [TBL] [Abstract][Full Text] [Related]
6. Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides. Heuts J; Varypataki EM; van der Maaden K; Romeijn S; Drijfhout JW; van Scheltinga AT; Ossendorp F; Jiskoot W Pharm Res; 2018 Sep; 35(11):207. PubMed ID: 30209623 [TBL] [Abstract][Full Text] [Related]
7. Liposomes as vaccine delivery systems: a review of the recent advances. Schwendener RA Ther Adv Vaccines; 2014 Nov; 2(6):159-82. PubMed ID: 25364509 [TBL] [Abstract][Full Text] [Related]
8. Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio. Hamborg M; Rose F; Jorgensen L; Bjorklund K; Pedersen HB; Christensen D; Foged C Biochim Biophys Acta; 2014 Aug; 1838(8):2001-10. PubMed ID: 24769435 [TBL] [Abstract][Full Text] [Related]
9. The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses. Ma Y; Zhuang Y; Xie X; Wang C; Wang F; Zhou D; Zeng J; Cai L Nanoscale; 2011 May; 3(5):2307-14. PubMed ID: 21499635 [TBL] [Abstract][Full Text] [Related]
10. Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity. Varypataki EM; van der Maaden K; Bouwstra J; Ossendorp F; Jiskoot W AAPS J; 2015 Jan; 17(1):216-26. PubMed ID: 25387996 [TBL] [Abstract][Full Text] [Related]
11. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance. Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804 [TBL] [Abstract][Full Text] [Related]
12. Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection. Mazumder S; Maji M; Ali N PLoS Negl Trop Dis; 2011 Dec; 5(12):e1429. PubMed ID: 22206029 [TBL] [Abstract][Full Text] [Related]
13. The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome. Yan W; Huang L Int J Pharm; 2009 Feb; 368(1-2):56-62. PubMed ID: 18992312 [TBL] [Abstract][Full Text] [Related]
14. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776 [TBL] [Abstract][Full Text] [Related]
15. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Carstens MG; Camps MG; Henriksen-Lacey M; Franken K; Ottenhoff TH; Perrie Y; Bouwstra JA; Ossendorp F; Jiskoot W Vaccine; 2011 Jun; 29(29-30):4761-70. PubMed ID: 21565240 [TBL] [Abstract][Full Text] [Related]
16. Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy. Zamani P; Momtazi-Borojeni AA; Nik ME; Oskuee RK; Sahebkar A J Cell Physiol; 2018 Jul; 233(7):5189-5199. PubMed ID: 29215747 [TBL] [Abstract][Full Text] [Related]
18. Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell Immunotherapy. Nagy NA; Castenmiller C; Vigario FL; Sparrius R; van Capel TMM; de Haas AM; van Kooyk Y; van Ree R; Tas SW; Geijtenbeek TBH; Jiskoot W; Slütter B; de Jong EC J Pharm Sci; 2022 Apr; 111(4):1081-1091. PubMed ID: 35114209 [TBL] [Abstract][Full Text] [Related]
19. Biodegradable nanoplatforms for antigen delivery: part I - state of the art review of polymeric nanoparticles for cancer immunotherapy. Vega E; Burgos JM; Souto EB; García ML; Pujol M; Sánchez-López E Expert Opin Drug Deliv; 2024 Aug; 21(8):1251-1262. PubMed ID: 39245953 [TBL] [Abstract][Full Text] [Related]
20. Nanovaccines: A game changing approach in the fight against infectious diseases. Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]